扎科普里德可以刺激人体心房中的5-HT4 血清素受体
Joachim Neumann1, Christin Hesse2, Britt Hofmann3
1Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, D-06097, Halle (Saale), Germany. joachim.neumann@medizin.uni-halle.de.
Naunyn-Schmiedeberg's archives of pharmacology
|April 1, 2024
概括
扎科普里德作为人体心房中的血清素5-HT4受体激动剂,增加心脏收缩力和速度. 这一发现表明,对于涉及这些受体的心脏病的潜在治疗应用.
科学领域:
- 心血管药理学心血管药理学
- 分子心脏病学分子心脏病学
- 血清素受体研究研究 血清素受体研究
背景情况:
- 扎科普里德是胃肠道中已知的5-HT4 血清素受体激动剂.
- 它的潜在心脏作用,特别是人类心脏中的5-HT4受体,仍然在很大程度上未被探索.
- 之前的研究推测,扎科普里德通过通道抑制具有抗失律的潜力.
研究的目的:
- 为了调查扎科普里德是否刺激人类心脏的5-HT4 血清素受体.
- 为了确定扎科普里德是否对人类心房组织产生积极的内和长作用.
- 阐明5-HT4受体在中介扎科普里德心脏作用中的作用.
主要方法:
- 测试扎科普里德对隔离的小鼠心房制剂的影响,这些药物过度表达了人类的5-HT4受体 (5-HT4-TG) 和野生型 (WT) 心脏.
- 评估扎科普里德对人类右心房准备剂 (HAP) 收缩力和心跳率的影响.
- 评估5-HT4受体对抗剂 (热皮塞特龙,GR125487) 和PDE III抑制剂 (西洛斯塔米德) 对扎科普里德在HAP中的作用的影响.
主要成果:
- 扎科普里德显著增加了5-HT4-TG小鼠心房的收缩力和心跳率,但不是WT心脏.
- 血清激素产生了类似的积极的内和长效应,如5-HT4-TG心脏准备中的扎科普里德.
- 扎科普里德在人类右心房制剂中表现出积极的内效应,该效应被5-HT4受体对抗剂阻断.
结论:
- 扎科普里德作为人类心脏5-HT4血清素受体的功能激动剂.
- 这些发现支持了萨科普里德刺激人类心房中的5-HT4受体的假设.
- 这表明扎科普里德在通过5-HT4通路调节心脏功能方面可能发挥作用.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
252
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
252
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
200
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
200
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
663
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
663
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.3K
Antipsychotic Drugs: Typical and Atypical Agents
194
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
194
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
281
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
281


